RISPOVAL 3 BRSV PI3 BVD LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION FOR CATTLE

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

BOVINE PARAINFLUENZA 3 VIRUS (PI3), RLB103, ATTENUATED BOVINE RESPIRATORY SYNCYTIAL VIRUS (BRSV), STRAIN 375 ATTENUATED BOVINE VIRAL DIARRHOEA VIRUS (BVD), STRAIN 5960, KILLED BOVINE VIRAL DIARRHOEA VIRUS (BVD), STRAIN 6309, KILLED

Mevcut itibaren:

Pfizer Healthcare Ireland

ATC kodu:

QI02AH

Farmasötik formu:

Lyophilisate for suspension for injection

Terapötik grubu:

Immunological - Mixed vaccine (live and inactivated)

Terapötik alanı:

Bovine

Yetkilendirme tarihi:

2005-06-03

Ürün özellikleri

IRISH MEDICINES BOARD ACT 1995
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
(S.I. NO. 786 OF 2007)
VPA: 10019/103/001
Case No: 7006680
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
PFIZER HEALTHCARE IRELAND TRADING AS PFIZER ANIMAL HEALTH
TRADING AS PFIZER ANIMAL HEALTH, RINGASKIDDY, CO. CORK, IRELAND
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
RISPOVAL 3 BRSV PI3 BVD LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION FOR CATTLE
The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may
be specified in the said Schedule.
The authorisation, unless previously revoked, shall continue in force from 26/03/2010.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: From this date of effect, this authorisation replaces any previous authorisation in respect of this product which is now null and void.)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 14/04/2010_
_CRN 7006680_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Rispoval 3 BRSV Pi3 BVD
Lyophilisate and suspension for suspension for injection for cattle.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Lyophilisate and suspension for suspension for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
One dose (4 ml) contains:
ACTIVE INGREDIENT(S):
_LYOPHILISED